Concepedia

Thierry Taverne

TT

6

Publications

429

Citations

6

H-Index

1998

Active since

Affiliations

Institut de Chimie(Current)

University of Namur

Thierry Taverne is an author at Institut de Chimie specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryBiochemistryNatural SciencesBioorganic ChemistryPharmacotherapyDrug DevelopmentOncology

Publications per year

1998–2014

6

Publications

6

RAC1 Inhibition Targets Amyloid Precursor Protein Processing by γ-Secretase and Decreases Aβ Production in Vitro and in Vivo

Laurent Désiré, Jérôme Bourdin, Nadia Loiseau et al. · Journal of Biological Chemistry · 2005 · 136 citations · Full text

New COX-2/5-LOX Inhibitors: Apoptosis-Inducing Agents Potentially Useful in Prostate Cancer Chemotherapy

Nicole Pommery, Thierry Taverne, Aurélie Telliez et al. · Journal of Medicinal Chemistry · 2004 · 122 citations · Full text

Bioorganic Chemistry, Cell Death, Pharmacotherapy +21

Synthesis and Activity of a New Methoxytetrahydropyran Derivative as Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitor

S. Barbey, Laurence Goossens, Thierry Taverne et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 65 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +10

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II

Alicia Foucourt, Damien Hédou, Carole Dubouilh‐Benard et al. · Molecules · 2014 · 48 citations · Full text

Down Syndrome, Combinatorial Chemistry, Medicinal Chemistry +15

Novel Benzothiazolin-2-one and Benzoxazin-3-one Arylpiperazine Derivatives with Mixed 5HT<sub>1A</sub>/D<sub>2</sub>Affinity as Potential Atypical Antipsychotics

Thierry Taverne, Ousmane Diouf, Patrick Depreux et al. · Journal of Medicinal Chemistry · 1998 · 39 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +17

Rows per page

1–5 of 6